Skip to main content
Top
Published in: World Journal of Surgery 7/2014

01-07-2014

Preoperative MRI of the Breast (POMB) Influences Primary Treatment in Breast Cancer: A Prospective, Randomized, Multicenter Study

Authors: Virginia Gonzalez, Kerstin Sandelin, Anders Karlsson, Wiveca Åberg, Lars Löfgren, Gabriela Iliescu, Staffan Eriksson, Brita Arver

Published in: World Journal of Surgery | Issue 7/2014

Login to get access

Abstract

Background

Breast magnetic resonance imaging (MRI) has shown high sensitivity in determining tumor extent, multifocality, and occult contralateral breast cancer. Low specificity, unnecessary mastectomies, and costs are arguments against MRI. The purpose of this study was to determine whether preoperative breast MRI would affect primary surgical management, reduce reexcision/reoperation procedures, and influence the choice of neoadjuvant treatment in patients with newly diagnosed breast cancer.

Methods

This prospective, randomized, multicenter study included 440 breast cancer patients younger than aged 56 years from three, Swedish, large-volume breast units. Patients were randomly allocated on a 1:1 basis to either preoperative staging with breast MRI (n = 220) or no breast MRI (n = 220) (control group). Treatment planning of all patients was discussed at multidisciplinary team conferences.

Results

In patients randomized to the MRI group, who had an observed higher percentage of planned breast-conserving surgery (BCS) compared with the control group, a change from suggested breast conservation to mastectomy occurred in 23 of 153 (15 %) patients. Breast MRI provided additional information in 83 of 220 (38 %) patients, which caused a change in treatment plan in 40 (18 %). The breast reoperation rate was significantly lower in the MRI group: 11 of 220 (5 %) versus 33 of 220 (15 %) in the control group (p < 0.001). The number of mastectomies, axillary reoperations, and the number of patients receiving neoadjuvant chemotherapy after definitive treatment did not differ significantly between the groups.

Conclusions

Preoperative staging with breast MRI in women younger than age 56 years altered the treatment plan in 18 % of the patients. Although a higher MRI-related conversion rate from breast conservation to mastectomy was found, the final numbers of mastectomies did not differ between the two groups. The breast reoperation rate in the MRI group was significantly reduced.
Appendix
Available only for authorised users
Literature
1.
go back to reference Drew P, Turnbull L, Chatterjee S et al (1999) Prospective comparison of standard triple assessment and dynamic magnetic resonance imaging of the breast for the evaluation of symptomatic breast lesion. Ann Surg 230(5):680PubMedCentralPubMedCrossRef Drew P, Turnbull L, Chatterjee S et al (1999) Prospective comparison of standard triple assessment and dynamic magnetic resonance imaging of the breast for the evaluation of symptomatic breast lesion. Ann Surg 230(5):680PubMedCentralPubMedCrossRef
2.
go back to reference Rodenko GN, Harms SE, Pruneda JM et al (1996) MR imaging in the management before surgery of lobular carcinoma of the breast: correlation with pathology. Am J Roentgenol 167(6):1415–1419CrossRef Rodenko GN, Harms SE, Pruneda JM et al (1996) MR imaging in the management before surgery of lobular carcinoma of the breast: correlation with pathology. Am J Roentgenol 167(6):1415–1419CrossRef
3.
go back to reference Carney P, Miglioretti D, Bonnie C et al (2003) Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 138:168–175PubMedCrossRef Carney P, Miglioretti D, Bonnie C et al (2003) Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 138:168–175PubMedCrossRef
4.
go back to reference Van Goethem M, Tjalma W, Schelfout K et al (2006) Magnetic resonance imaging in breast cancer. Eur J Surg Oncol 32(9):901–910PubMedCrossRef Van Goethem M, Tjalma W, Schelfout K et al (2006) Magnetic resonance imaging in breast cancer. Eur J Surg Oncol 32(9):901–910PubMedCrossRef
5.
go back to reference Berg WA, Gutierrez L, NessAiver MS et al (2004) Diagnostic accuracy of mammography, clinical examination, US and MR imaging in preoperative assessment of breast cancer. Radiology 233:830–849PubMedCrossRef Berg WA, Gutierrez L, NessAiver MS et al (2004) Diagnostic accuracy of mammography, clinical examination, US and MR imaging in preoperative assessment of breast cancer. Radiology 233:830–849PubMedCrossRef
6.
go back to reference Plevritis SK, Kurian AW, Sigal BM et al (2006) Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA 295(20):2374–2384PubMedCrossRef Plevritis SK, Kurian AW, Sigal BM et al (2006) Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA 295(20):2374–2384PubMedCrossRef
7.
go back to reference Saslow D, Boetes C, Burke W et al (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57(2):75–89PubMedCrossRef Saslow D, Boetes C, Burke W et al (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57(2):75–89PubMedCrossRef
8.
go back to reference Atkins JJ, Appleton CM, Fisher CS et al (2013) Which imaging modality is superior for prediction of response to neoadjuvant chemotherapy in patients with triple negative breast cancer? J Oncol 2013:964863PubMedCentralPubMedCrossRef Atkins JJ, Appleton CM, Fisher CS et al (2013) Which imaging modality is superior for prediction of response to neoadjuvant chemotherapy in patients with triple negative breast cancer? J Oncol 2013:964863PubMedCentralPubMedCrossRef
9.
go back to reference Houssami N, Turner R, Morrow M (2013) Preoperative magnetic resonance imaging in breast cancer meta-analysis of surgical outcomes. Ann Surg 257:249–255PubMedCrossRef Houssami N, Turner R, Morrow M (2013) Preoperative magnetic resonance imaging in breast cancer meta-analysis of surgical outcomes. Ann Surg 257:249–255PubMedCrossRef
10.
go back to reference Checka CM, Chun JE, Schnabel FR et al (2012) The relationship of mammographic density and age: implication for breast cancer screening. Am J Roentgenol 198(3):292–295CrossRef Checka CM, Chun JE, Schnabel FR et al (2012) The relationship of mammographic density and age: implication for breast cancer screening. Am J Roentgenol 198(3):292–295CrossRef
11.
go back to reference Wolfe JN, Albert S, Belle S et al (1983) Brest parenchymal patterns and their relationship to risk for having or developing carcinoma. Radiol Clin North Am 21:127–136PubMed Wolfe JN, Albert S, Belle S et al (1983) Brest parenchymal patterns and their relationship to risk for having or developing carcinoma. Radiol Clin North Am 21:127–136PubMed
13.
go back to reference Bergkvist L, Frisell J, Swedish Breast Cancer Group, Swedish Society of Breast Surgeons (2005) Multicentre validation study of sentinel node biopsy for staging in breast cancer. Br J Surg 92(10):1221–1224PubMedCrossRef Bergkvist L, Frisell J, Swedish Breast Cancer Group, Swedish Society of Breast Surgeons (2005) Multicentre validation study of sentinel node biopsy for staging in breast cancer. Br J Surg 92(10):1221–1224PubMedCrossRef
14.
go back to reference Andersson Y, Frisell J, Sylvan M et al (2013) Causes of false-negative sentinel node biopsy in patients with breast cancer. Br J Surg 100(6):775–783PubMedCrossRef Andersson Y, Frisell J, Sylvan M et al (2013) Causes of false-negative sentinel node biopsy in patients with breast cancer. Br J Surg 100(6):775–783PubMedCrossRef
16.
go back to reference Bedrosian I, Mick R, Orel SG et al (2003) Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 98(3):468–473PubMedCrossRef Bedrosian I, Mick R, Orel SG et al (2003) Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 98(3):468–473PubMedCrossRef
17.
go back to reference Turnbull L, Brown S, Harvey I et al (2010) Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 375:563–571PubMedCrossRef Turnbull L, Brown S, Harvey I et al (2010) Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 375:563–571PubMedCrossRef
18.
go back to reference Peters NH, van Esser S, van den Bosch MA et al (2011) Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET—randomised controlled trial. Eur J Cancer 47(6):879–886PubMedCrossRef Peters NH, van Esser S, van den Bosch MA et al (2011) Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET—randomised controlled trial. Eur J Cancer 47(6):879–886PubMedCrossRef
19.
go back to reference Kuhl C, Kuhn W, Braun M et al (2007) Pre-operative staging of breast cancer with breast MRI: one step forward, two steps back? Breast 16:S34–S44PubMedCrossRef Kuhl C, Kuhn W, Braun M et al (2007) Pre-operative staging of breast cancer with breast MRI: one step forward, two steps back? Breast 16:S34–S44PubMedCrossRef
Metadata
Title
Preoperative MRI of the Breast (POMB) Influences Primary Treatment in Breast Cancer: A Prospective, Randomized, Multicenter Study
Authors
Virginia Gonzalez
Kerstin Sandelin
Anders Karlsson
Wiveca Åberg
Lars Löfgren
Gabriela Iliescu
Staffan Eriksson
Brita Arver
Publication date
01-07-2014
Publisher
Springer US
Published in
World Journal of Surgery / Issue 7/2014
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-014-2605-0

Other articles of this Issue 7/2014

World Journal of Surgery 7/2014 Go to the issue